CrowdMed, Inc.

CrowdMed, Inc. is a pioneering medical case-solving platform that connects patients with a global community of experts to collaboratively diagnose complex medical conditions. Founded in 2012 in San Francisco, US, CrowdMed, Inc. specializes in connecting patients with a network of Medical Detectives for case diagnosis.

The company has undergone no significant pivots in strategy. CrowdMed secured funding through a Seed round, raising USD 0. 77 mn from investors including Andreessen Horowitz and Y Combinator, leading to a total amount raised of USD 0. 77 mn.

The CEO is Danyell Munassi alongside Painin Derarse. CrowdMed offers a unique case-solving platform that connects patients with a global community of Medical Detectives, aiming to diagnose complex medical cases. Patients initiate the process by submitting their medical history, current symptoms, and personal stories through an online questionnaire, which enables the community to analyze the case collaboratively. The outcome is a comprehensive report that includes top diagnostic suggestions and recommended solutions for patients to discuss with their healthcare providers.

This innovative service is available to users across more than 30 countries, catering to a diverse clientele that includes individual patients seeking answers to their medical mysteries. Additionally, the company provides a suite of marketing automation software designed to enhance efficiency and streamline marketing efforts, further broadening its service offerings to small businesses and large enterprises. CrowdMed generates revenue primarily through subscription-based pricing plans tailored to different client needs. The offerings include a Basic plan for small businesses at USD 4.

95 per month, a Professional plan at USD 9. 95 per month—most popular among clients—and an Enterprise plan designed for larger companies priced at USD 14. 95 per month. Each plan provides users with unlimited updates and product access, as well as features that can be customized based on client requirements.

Transactions are structured on a subscription basis, allowing for continuous engagement with both patients and businesses utilizing the CrowdMed platform. Following its most recent deal in February 2017, CrowdMed plans to leverage the venture financing from Mindset Ventures to enhance its platform capabilities. Future growth strategies include expanding into additional international markets to broaden access to its services, although specific targets and timelines for these expansions are not disclosed at this time.